Form 4 Tracker
BeOne Medicines Ltd.
ONC

52 insider filings · Latest: Aug 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 23, 2025Jun 23 8:08 PMJOHN OYLER
Proposed Sale
3,174$261.61$830.4K

View →

Jun 17, 2025Jun 17 8:20 PMJOHN OYLER
Proposed Sale
1,460$256.49$374.5K

View →

Jun 17, 2025Jun 17 8:19 PMLAI WANG
Proposed Sale
470$251.37$118.1K

View →

Jun 17, 2025Jun 17 8:18 PMXIAOBIN WU
Proposed Sale
630$250.87$158.0K

View →

Jun 16, 2025Jun 16 8:16 PMXIAOBIN WU
Proposed Sale
1,543$266.52$411.2K

View →

Jun 16, 2025Jun 16 8:15 PMCHAN LEE
Proposed Sale
422$266.50$112.5K

View →

Jun 16, 2025Jun 16 8:14 PMJOHN OYLER
Proposed Sale
3,680$266.05$979.0K

View →

Jun 16, 2025Jun 16 8:03 PMLAI WANG
Proposed Sale
1,177$266.40$313.6K

View →

Jun 11, 2025Jun 11 8:15 PMTITUS BENJAMIN BALL
Proposed Sale
134$258.36$34.6K

View →

Jun 6, 2025Jun 6 8:20 PMCHAN LEE
Proposed Sale
700$256.11$179.3K

View →

Jun 6, 2025Jun 6 8:19 PMLAI WANG
Proposed Sale
1,402$252.39$353.9K

View →

Jun 6, 2025Jun 6 8:16 PMJOHN OYLER
Proposed Sale
5,127$252.77$1.3M

View →

Jun 6, 2025Jun 6 8:13 PMXIAOBIN WU
Proposed Sale
1,934$253.15$489.6K

View →

Apr 14, 2025Apr 14 8:21 PMXIAODONG WANG
Proposed Sale
125,280$230.36$28.9M

View →

Apr 1, 2025Apr 1 8:27 PMXIAOBIN WU
Proposed Sale
51,921$272.17$14.1M

View →

Mar 10, 2025Mar 10 9:51 PMJOHN OYLER
Proposed Sale
41,210$242.67$10.0M

View →

Mar 10, 2025Mar 10 8:19 PMJOHN OYLER
Proposed Sale
41,210$242.67$10.0M

View →

Mar 7, 2025Mar 7 10:14 PMJOHN OYLER
Proposed Sale
58,590$249.13$14.6M

View →

Mar 6, 2025Mar 6 10:22 PMJOHN OYLER
Proposed Sale
40,109$259.15$10.4M

View →

Mar 5, 2025Mar 5 9:26 PMXIAOBIN WU
Proposed Sale
51,921$257.31$13.4M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 11, 2026Aug 14 12:54 AMChan Henry LeeSVP, General Counsel
Option Exercise
34,65888,582(D)

View →

Jul 22, 2026Jul 24 8:51 PMChan Henry LeeSVP, General Counsel
Option Exercise
21,69798,930(D)

View →

Jul 20, 2026Jul 22 9:03 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
441,8700(D)

View →

Jul 17, 2026Jul 17 9:36 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
840,164441,870(D)

View →

Jul 16, 2026Jul 17 9:31 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
2,165,7611,282,034(D)

View →

Jul 15, 2026Jul 17 9:31 PMJohn OylerDirector, Chief Executive Officer
Option Exercise
1,515,2411,254,513(D)

View →

Jul 14, 2026Jul 15 1:26 AMJohn OylerDirector, Chief Executive Officer
Option Exercise
1,736,800462,866(D)

View →

Jul 13, 2026Jul 15 1:25 AMJohn OylerDirector, Chief Executive Officer
Option Exercise
630,7601,264,666(D)

View →

Jul 10, 2026Jul 15 1:25 AMJohn OylerDirector, Chief Executive Officer
Option Exercise
152,0741,895,426(D)

View →

Jul 8, 2026Jul 10 8:44 PMChan Henry LeeSVP, General Counsel
Option Exercise
8,632105,300(D)

View →

Jun 11, 2026Jun 15 9:55 PMLai WangPresident, Global Head of R&D
Grant/Award
229,775229,775(D)

View →

Jun 11, 2026Jun 15 9:55 PMAaron RosenbergChief Financial Officer
Grant/Award
137,865137,865(D)

View →

Jun 11, 2026Jun 15 9:55 PMXiaobin WuPresident and COO
Grant/Award
229,775229,775(D)

View →

Jun 11, 2026Jun 15 9:55 PMChan Henry LeeSVP, General Counsel
Grant/Award
87,30887,308(D)

View →

Jun 11, 2026Jun 15 9:55 PMJohn OylerDirector, Chief Executive Officer
Grant/Award
344,669344,669(D)

View →

Jun 11, 2026Jun 15 9:54 PMXiaodong WangDirector, Other
Grant/Award
193,492193,492(D)

View →

May 13, 2026May 15 8:39 PMChan Henry LeeSVP, General Counsel
Option Exercise
4,316107,848(D)

View →

Apr 8, 2026Apr 10 9:40 PMChan Henry LeeSVP, General Counsel
Option Exercise
4,316109,122(D)

View →

Mar 11, 2026Mar 13 9:26 PMChan Henry LeeSVP, General Counsel
Option Exercise
4,433110,396(D)

View →

Feb 4, 2026Feb 6 9:57 PMChan Henry LeeSVP, General Counsel
Option Exercise
21,580111,670(D)

View →